Michel, J. -P., Gusmano, M., Blank, P.R. and Philp, Ian. (2010) Vaccination and healthy ageing : how to make life-course vaccination a successful public health strategy. European Geriatric Medicine, Vol.1 (No.3). pp. 155-165. ISSN 18787649

Full text not available from this repository.

Abstract

Vaccine guidelines that advocate immunisation in adults aged >= 60 years and an international policy brief that explores the importance of life-course vaccination have been proposed. The guidelines, policy brief and associated data were considered by experts at two meetings during 2009. This paper amalgamates those discussions and recommends practical strategies that may contribute to the successful implementation of adult vaccination. The challenges posed by changes in the global age distribution may be confronted by preparing for healthy ageing early in life - a 'life-course' approach to health. Vaccination can provide cost-effective protection against a host of diseases throughout life, but remains an underused public-health strategy in adults for the promotion of healthy ageing. Without specific vaccination programmes for the adult population aged >= 50 years ('50+ vaccine programmes') infectious diseases will continue to be a cause of substantial morbidity and mortality in late adulthood. The reasons for low vaccination rates among adults ('what we know') are identified and the four common determinants for the successful implementation of 50+ vaccination programmes ('what we should do') are examined: vaccination programme objectives, the role of healthcare professionals, access to vaccines, and public awareness. To achieve the goal of healthy ageing, nationally customised measures should be instigated to address these determinants in the 50+ age group and to ensure access to vaccination for those who are expected to benefit. (C) 2010 Elsevier Masson SAS and European Union Geriatric Medicine Society. All rights reserved.

Item Type:	Journal Article
Subjects:	R Medicine > R Medicine (General) R Medicine > RA Public aspects of medicine > RA0421 Public health. Hygiene. Preventive Medicine
Divisions:	Faculty of Medicine > Warwick Medical School
Library of Congress Subject Headings (LCSH):	Vaccination, Aging, Medical policy, Immunization, Age distribution (Demography), Older people -- Health and hygiene
Journal or Publication Title:	European Geriatric Medicine
Publisher:	Elsevier Ltd
ISSN:	18787649
Date:	June 2010
Volume:	Vol.1
Number:	No.3
Page Range:	pp. 155-165
Identification Number:	10.1016/j.eurger.2010.03.013
Status:	Not Peer Reviewed
Publication Status:	Published
Access rights to Published version:	Restricted or Subscription Access
Funder:	Merck Sharp & Dohme, Sanofi Pasteur MSD, ,
References:	[1] Michel JP, Chidiac C, Grubeck-Loebenstein B, et al. Advocating vaccination of adults aged 60 years and older in western Europe: statement by the Joint VaccineWorking Group of the European Union Geriatric Medicine Society and the International Association of Gerontology and Geriatrics - European Region. Rejuvenation Res 2009;12:127–35. [2] Michel JP, Chidiac C, Grubeck-Loebenstein B, et al. Coalition of advocates to vaccinate of Western European citizens aged 60 years and older. Aging Clin Exp Res 2009;21:254–7. [3] Gusmano MK, Michel JP. Life course vaccination, impact of life course vaccination on an ageing population. In: Alliance for health and the future–France; 2009: p. 1–8. Available online: http://www.ilcusa.org/pages/publications/ healthy-aging/life-course-vaccination-impact-of-life-course-vaccination-onan- ageing-population.php. Accessed on 21.03.10. [4] Vaccination and health ageing. Plenary Panel at the 5th World Ageing and Generations Congress (University of St. Gallen, Switzerland, 2009). Available online: http://www.unistgallen.ch/hsgweb.nsf/SysWebRessources/World+Ageing+ Congress+Programm/$FILE/wda_programm_2009.pdf. Accessed on 21.03.10. [5] ‘Immunisation of adults and elderly: how to make a successful public health strategy’. Round-table discussion at the 2nd EUPHA meeting (Lodz, Poland, 2009). Available online: http://www.eupha.org/documents/upcoming_conference/ 2009/EUPHA_2009_Immunisation_of_adults_and_elderly.pdf. Accessed on 21.03.10. [6] UN World Population Ageing: 1950-2050. Population Division DESA, United Nations, New York, NY, 2001; p. 79 Available online: http://www.un.org/esa/ population/publications/worldageing19502050/pdf/016europ.pdf. Accessed on 21.03.10. [7] Michel JP, GoldG.Copingwithpopulationagingin the oldcontinent–the need for European academic geriatrics. J Gerontol A Biol Sci Med Sci 2001;56:M341–3. [8] Active ageing: a policy framework. World Health Organization, Geneva, 2002, (WHO/NMH/NPH/02.8). Available online: http://whqlibdoc.who.int/hq/2002/ WHO_NMH_NPH_02.8.pdf. Accessed on 21.03.10. [9] Michel JP, Newton JL, Kirkwood TBL. Medical challenges of improving the quality of a longer life. JAMA 2008;299:688–90. [10] Butler RN. The longevity revolution: the benefits and challenges of living a long life. New York, NY: Public Affairs; 2008. [11] Elder Jr GH, JohnsonMK. The life course and aging: challenges, lessons and new directions. In: Settersten Jr RA, editor. Invitation to the life course: toward new understandings of later life, part II. Amityville, NY: Baywood; 2002. p. 49–81. [12] Elder Jr GH, Giele JZ, editors. The craft of life course research. New York, NY: Guilford Press; 2009. [13] Stein C, Moritz I. A life course perspective of maintaining independence in older age. World Health Organization, Geneva, 1999. Available online: http:// whqlibdoc.who.int/hq/1999/WHO_HSC_AHE_99.2_life.pdf. Accessed on 21.03.10. [14] Strehler BL, Mildvan AS. General theory of mortality and aging. Science 1960;132:14–21. [15] Walford RL. The immunologic theory of aging. Copenhagen: Munksgaard Press; 1969. [16] Gavazzi G, Krause KH. Ageing and infection. Lancet Infect Dis 2002;2:659–66. [17] Aspinall R, Del Giudice G, Effros RB, et al. Challenges for vaccination in the elderly. Immun Ageing 2007;4:9. [18] Centers for Disease Control. Pneumonia and influenza death rates–United States, 1979–1994. MMWR Morb Mortal Wkly Rep 1995; 44:535–37. Available online: http://www.cdc.gov/mmwr/preview/mmwrhtml/00039389.htm. Accessed on 21.03.10. [19] High K. Immunizations in older adults. Clin Geriatr Med 2007;23:669–85 [viii– viii]. [20] Plotkin S. A short history of vaccination. In: Plotkin SA, Orenstein WA, Offit PA, editors. Vaccines. 5th edition, Amsterdam: Elsevier Health Sciences; 2008. p. 1–16. [21] Perception of vaccines and vaccinations EVM Study Number 41039032. International Management Summary Report 4, April, 2004. Available online: http://www.evm-vaccines.org/pdfs/survey_perceptions_fin.pdf. Accessed on 21.03.10. [22] Poland GA, Jacobson RM, Ovsyannikova IG. Trends affecting the future of vaccine development and delivery: the role of demographics, regulatory science, the anti-vaccine movement, and vaccinomics. Vaccine 2009;27: 3240–4. [23] Fingar AR, Francis BJ. American college of preventive medicine practice policy statement: adult immunizations. Am J Prev Med 1998;14:156–8. [24] Vitek CR, Wharton M. Diphtheria in the former Soviet Union: reemergence of a pandemic disease. Emerg Infect Dis 1998;4:539–50. [25] WHO Centralized information system for infectious diseases (CISID) Available online: http:/data.euro.who.int/cisid/. [26] de Greeff SC, Mooi FR, Schellekens JF, et al. Impact of acellular pertussis preschool booster vaccination on disease burden of pertussis in The Netherlands. Pediatr Infect Dis J 2008;27:218–23. [27] Gergen PJ, McQuillan GM, Kiely M, et al. A population-based serologic survey of immunity to tetanus in the United States. N Engl J Med 1995;332:761–6. [28] Suhrcke M, McKee M, Sauto Arce R, et al. The contribution of health to the economy in the European Union. Health and Consumer Protection Directorate General. Office for Official Publications of the European Communities, Luxembourg 2005. Available online: http://ec.europa.eu/health/ph_overview/ Documents/health_economy_en.pdf. Accessed on 21.03.10. [29] Siegrist CA. Vaccinology update 2005: a new category of recommendations for optimal vaccine protection. Rev Med Suisse 2006;2:67–70 [In French]. [30] Zimmerman RK, Middleton DB, Burns IT, et al. Routine vaccines across the life span. J Fam Pract 2007;56(Suppl. 2) [S18–S37, C1–C3]. [31] World Health Assembly. Prevention and control of influenza pandemics and annual epidemics. Fifty-sixth World Health Assembly; Resolution WHA56.19. 28 May 2003. WHO, Geneva, 2003. Available online: http://www.evm-vaccines. org/pdfs/wha_resolution_ipd.pdf. Accessed on 21.03.10. [32] European Parliament. Strategy against an influenza pandemic. European Parliament resolution P6_TA(2005)0406. 26 October 2005. European Parliament, Brussels, 2005. Available online: http://www.europarl.europa.eu/sides/ getDoc.do?type=TA&reference=P6-TA-2005-0406&language=EN. Accessed on 21.03.10. [33] Council recommendation of 22 December 2009 on seasonal influenza vaccination (Text with EEA relevance) (2009/1019/EU). Off J Eur Union 2009; 348:71-2. Available online: http://eur-lex.europa.eu/LexUriServ/LexUriServ.- do?uri=OJ:L:2009:348:0071:0072:EN:PDF Accessed on 21.03.10. [34] Blank PR, Schwenkglenks M, Szucs TD. Vaccination coverage rates in eleven European countries during two consecutive influenza seasons. J Infect 2009;58:446–58. [35] Samson S, Me´gard Y. Overview of vaccination policies for the elderly in Western European countries. Aging Clin Exp Res 2009;21:210–5. [36] Chen WH, Kozlovsky BF, Rita B, et al. Vaccination in the elderly: an immunological perspective. Trends Immunol 2009;30:351–9. [37] Htwe TH, Mushtaq A, Robinson SB, et al. Infection in the elderly. Infect Dis Clin North Am 2007;21:711–43 [ix]. [38] Liang SY, Mackowiak PA. Infections in the elderly. Clin Geriatr Med 2007;23:441–56 [viii]. [39] Targonski PV, Jacobson RM, Poland GA. Immunosenescence: role and measurement in influenza vaccine response among the elderly. Vaccine 2007;25: 3066–9. [40] Pawelec G, Akbar A, Caruso C, et al. Human immunosenescence: is it infectious? Immunol Rev 2005;205:257–68. [41] Lamontagne F, Garant MP, Carvalho JC, et al. Pneumococcal vaccination and risk of myocardial infarction. CMAJ 2008;179(8):773–7. [42] Gurfinkel EP, Leon de la Fuente R, Mendiz O, et al. Flu vaccination in acute coronary syndromes and planned percutaneous coronary interventions (FLUVACS) Study. Eur Heart J 2004;25:25–31. [43] Nichol KL, D’Heilly SJ, Greenberg ME, et al. Burden of influenza-like illness and effectiveness of influenza vaccination among working adults aged 50–64 years. Clin Infect Dis 2009;48:292–8. Available online: http://www.journals. uchicago.edu/doi/full/10.1086/595842. Accessed on 21.03.10. [44] Bridges CB, Harper SA, Fukuda K, et al. Prevention and control of influenza. Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 2003;52:1–34 [Erratum in:MMWR Morb Mortal Wkly Rep 2003;52:526]. Available online: http://www.cdc.gov/mmwr/preview/ mmwrhtml/rr5208a1.htm. [45] Daily P, Rothrock G, Barrett N. Direct and indirect effects of routine vaccination of children with 7-valent pneumococcal conjugate vaccine on incidence of invasive pneumococcal disease–United States, 1998–2003. MMWR Morb Mortal Wkly Rep 2005;54:893–7. Available online: http://www.cdc.gov/ mmwr/preview/mmwrhtml/mm5436a1.htm. Accessed on 21.03.10. [46] Reichert TA, Sugaya N, Fedson DS, et al. The Japanese experience with vaccinating school children against influenza. N Engl J Med 2001;344:889–96. [47] Bovier PA, Chamot E, Bouvier Gallacchi M, et al. Importance of patients’ perceptions and general practitioners’ recommendations in understanding missed opportunities for immunisations in Swiss adults. Vaccine 2001;19:4760–7. [48] Madelin R. Future challenges for EU health and customer policy. Director General SANCO Health and Consumer Protection Directorate General, editor. Brussels: European Commission; 2008. Available online: http://ec.europa.eu/ dgs/health_consumer/future_challenges/future_challenges_paper.pdf. Accessed on 21.03.10. [49] Mieczkowski TA, Wilson SA. Adult pneumococcal vaccination: a review of physician and patient barriers. Vaccine 2002;20:1383–92. [50] Motbey C. Pneumococcal polysaccharide vaccination in Australia: an examination of barriers and arguments in support of the hospital-based approach. Hum Vaccin 2008;4:341–3. [51] Szucs TD, Muller D. Influenza vaccination coverage rates in five European countries-a population-based cross-sectional analysis of two consecutive influenza seasons. Vaccine 2005;23:5055–63. [52] Zimmerman RK, Santibanez TA, Fine MJ, et al. Barriers and facilitators of pneumococcal vaccination among the elderly. Vaccine 2003;21:1510–7. [53] Bloom H. Immunizations: not just for kids. In: International Longevity Center – USA, editor. New York: International Longevity Center – USA; 2007; p. 1–8. Available online: http://www.ilcusa.org/media/pdfs/Immunizations_NotJust- ForKids.pdf. [54] Harris KM, Maurer J, Lurie N. Do people who intend to get a flu shot actually get one? J Gen Intern Med 2009;24:1311–3. [55] Griffin M, Shickle D, Moran N. European citizens’ opinions on water fluoridation. Community Dent Oral Epidemiol 2008;36:95–102. [56] Allsup SJ, Gosney MA. Difficulties of recruitment for a randomized controlled trial involving influenza vaccination in healthy older people. Gerontology 2002;48:170–3. [57] Graham L. Recommendations released on influenza vaccination of health care professionals. Am Fam Physician 2006;74:667–9. Available online: http:// www.aafp.org/afp/2006/0815/p665.html. Accessed on 21.03.10. [58] Blank PR, Schwenkglenks M, Szucs TD. Influenza vaccination coverage rates in five European countries during season 2006/07 and trends over six consecutive seasons. BMC Public Health 2008;8:272. Doi:10.1186/1471-2458-8-272. Available online: http://www.biomedcentral.com/1471-2458/8/272. Accessed on 21.03.10. [59] Gazmararian JA, Williams MV, Peel J, et al. Health literacy and knowledge of chronic disease. Patient Educ Couns 2003;51:267–75. [60] Jacobson TA, Thomas DM, Morton FJ, et al. Use of a low-literacy patient education tool to enhance pneumococcal vaccination rates. A randomized controlled trial. JAMA 1999;282:646–50. [61] Gusmano MK, Rodwin VG, Weisz D. Health care in world cities:. New York, Paris and London: Johns Hopkins University Press, Baltimore MD; 2010. [62] Schmitt HJ, Booy R, Aston R, et al. How to optimise the coverage rate of infant and adult immunisations in Europe. BMCMed 2007; 5:11. Doi:10.1186/1741- 7015-5-11. Available online: http://www.biomedcentral.com/1741-7015/5/ 11. Accessed on 21.03.10. [63] Rothan-Tondeur M, Filali-Zegzouti Y, Belmin J, et al. Health care worker influenza vaccination program assessment in French geriatric wards: a cluster- randomized controlled trial. Aging Clin Exp Res 2009 [Epub ahead of print], [PMID 19966539]. [64] Gavazzi G. Influenza vaccination for healthcare workers: from a simple concept to a resistant issue? Aging Clin Exp Res 2009;21:216–21. [65] Baeyens JP, Lang PO, Michel JP. Willingness to vaccinate and to be vaccinated in adults. Aging Clin Exp Res 2009;21:244–9. [66] Polgreen PM, Septimus EJ, Parry MF, et al. Relationship of influenza vaccination declination statements and influenza vaccination rates for healthcare workers in 22 US hospitals. Infect Control Hosp Epidemiol 2008;29:675–7. [67] Endrich MM, Blank PR, Szucs TD. Influenza vaccination uptake and socioeconomic determinants in 11 European countries. Vaccine 2009;27:4018–24. [68] Obrego´n R, Chitnis K, Morry C, et al. Achieving polio eradication: a review of health communication evidence and lessons learned in India and Pakistan. Bull World Health Organ 2009;87:624–30. [69] CDC Impact of vaccines universally recommended for children–United States, 1900-1998. MMWR 1999;48:243–8. Available online: http://www.cdc.gov/ mmwr/preview/mmwrhtml/00056803.htm. Accessed on 21.03.10. [70] CDC. Notice to readers: Final 2003 Reports of notifiable diseases. MMWR 2004;53:687. Available online: http://www.cdc.gov/mmwr/preview/ mmwrhtml/mm5330a6.htm. Accessed on 21.03.10.
URI:	http://wrap.warwick.ac.uk/id/eprint/41617

Data sourced from Thomson Reuters' Web of Knowledge

Request changes to a record

Actions (login required)

View Item